香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而 産生或因倚賴該等內容而引致的任何損失承擔任何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華寶國際控股有限公司 * （於百慕達註冊成立之有限公司） （股份代號：00336） 盈利警告 本公告乃由華寶國際控股有限公司（「本公司」，連同其附屬公司，統稱「本集 團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條 及香港法例第571章《證券及期貨條例》第XIVA部的內幕消息條文（定義見上市規 則）而作出。 本公司董事會（「董事會」）謹此知會本公司股東（「股東」）及有意投資者，根據 本集團對截至2024年12月31日止年度(「本年度」)的未經審核綜合管理賬目的初步審 閱以及董事會現時所得的其他資料，預期本集團於本年度將錄得稅前虧損介乎人民幣 3.05億元至人民幣4.55億元（包括商譽以及其他資產的非現金減值計提及其他計提 （「減值計提及其他計提」）），去年同期則錄得稅前利潤約人民幣4.16億元 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任 何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華 寶 國 際 控 股 有 限 公 司 * （於百慕達註冊成立之有限公司） （股份代號：00336） 內幕消息 華寶香精股份有限公司截至 2024 年 12 月 31 日止年度之 業績預告 本公告乃由華寶國際控股有限公司（「本公司」）根據香港聯合交易所有限公司證券上市規則 第13.09條刊發及香港法例第571章證券及期貨條例第XIVA部內幕消息條文而作出。 一、本期業績預計情況 本公司之董事會謹請本公司股東及公眾投資者留意此公告附錄（「附錄」）所載根據中國企業 會計準則編製之華寶股份就上述所提及之業績預告。 請注意附錄內資料乃摘錄自華寶股份以中文編制之財務數據。若中英文版有歧義，概以中文版 為准。 承董事會命 華寶國際控股有限公司 執行董事 潘昭國 香港，2025 年 1 月 24 日 於本公告日期，董事會由六名執行董事包括朱林 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲 明，並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 與客戶的關連交易 與客戶的交易 茲提述本公司分別刊登的首份公告、第二份公告及第三份公告。 自刊發第三份公告後，本集團成員公司已收到廣東中煙公司發出的採購訂單，所有 採購訂單均有關本集團成員公司向廣東中煙公司提供煙用生產原料。採購訂單的總 代價約為人民幣 34,952,841 元。 本公司間接持有廣東金科約 55.375%股權，廣東金科被視為本公司的間接擁有非全資 附屬公司。廣東中煙持有廣東金科 17.5%股權。根據上市規則，廣東中煙公司被視為 本公司附屬公司層面的關連人士。本集團與廣東中煙公司之間就有關銷售及購買煙 用生產原料等的交易構成本公司的關連交易。 上市規則的涵義 自刊發第三份公告後，本集團與廣東中煙公司於銷售協議項下的交易總金額約為人 民幣 34,952,841 元，而按獨立基準計算超過適用百分比率 1%，觸發本公司須重新遵 守上市規則第 14A 章規定的所有適用申報、披露及（如適用及需要）獨立股 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而 產生或因倚賴該等內容而引致的任何損失承擔任何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華 寶 國 際 控 股 有 限 公 司 * （於百慕達註冊成立之有限公司） 香港夏慤道16號 遠東金融中心17樓 電話 : (852) 2980 1333 傳真 : (852) 2810 8185 由2025年2月4日起, 有關本公司之股份過戶及登記手續將由卓佳證券登記 有限公司辦理。 於2025年2月3日下午四時三十分後仍未領取之股票, 可於 2025年2月4日起從卓佳證券登記有限公司領取。 承董事會命 華寶國際控股有限公司 執行董事 潘昭國 香港，2025年1月2日 （股份代號：00336） 更改香港股份過戶登記處 華寶國際控股有限公司（「本公司」）董事會（「董事會」）謹此宣佈， 本公司之香港股份過戶登記分處將於2025年2月4日更改為： 卓佳證券登記有限公司 * 僅供識別 1 於本公告日期，董事會由六名執行董事包括朱林瑤女士 ...

董事會謹此公佈，於2024年12月5日（交易時間後），本集團成員公司已向興業銀行 認購且於本公告日期仍未到期的該等金融產品合計投資總額為人民幣780,000,000元。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失 承擔任何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華 寶 國 際 控 股 有 限 公 司 * （於百慕達註冊成立之有限公司） 於本公告日期，董事確認（i）除該等金融產品仍未到期外，其餘的所有向興業銀行 認購的金融產品均已按照各自的條款悉數贖回；（ii）本集團相信認購該等金融產品 各自均獲得合理利息；及（iii）認購該等金融產品將不會對本集團的財務狀況造成任 何不利影響。 上市規則的涵義 （股份代號：00336） 須予披露交易 進一步認購金融產品 進一步認購金融產品 在認購第三項金融產品、第四項金融產品及第五項金融產品之前，由於根據上市規則 第14.07條就首項金融產品及第二項金融產品計算（無論是單獨計算或按合併基 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而 產生或因倚賴該等內容而引致的任何損失承擔任何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華 寶 國 際 控 股 有 限 公 司 * Conyers Corporate Services (Bermuda) Limited Clarendon House, 2 Church Street Hamilton HM11 Bermuda 卓佳登捷時有限公司仍為本公司之香港股份登記及過戶處，而於香港進行 股份過戶登記的申請須送交卓佳登捷時有限公司，其地址為香港夏愨道16 號遠東金融中心17樓。 承董事會命 華寶國際控股有限公司 執行董事 潘昭國 香港，2024年11月29日 於本公告日期，董事會由六名執行董事包括朱林瑤女士、林嘉宇先生、夏利群先生、潘昭國先生、 林嘉炘女士及蔡文霞女士；以及三名獨立非執行董事包括李祿兆先生、Jonathan Jun YAN 先生及 侯海濤先生組成。 * 僅供識別 1 （於百慕達註冊成立之有限公司 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華寶國際控股有限公司 * （於百慕達註冊成立之有限公司） （股份代號：00336） 內幕消息 關於附屬公司仲裁進展情況的公告 本公告是華寶國際控股有限公司（「本公司」，連同其附屬公司，統稱「本集團」）根據香港聯合 交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條以及香港法例第571章證券及期貨 條例第XIVA部項下的內幕消息條文（定義見上市規則）而作出。 茲提述本公司日期分別為2022年3月8日、2023年8月9日、2024年3月11日及2024年10月 8日的公告（統稱「該等公告」）。除非文義另有所指，否則本公告所用詞彙與該等公告所界定者 具有相同涵議。 於2022年3月8日，華寶香精股份有限公司（「華寶股份」（本公司的非全資附屬公司，其股份在 深圳證券交易所創業板上市（股份代號：300741）））、上海克瀝 ...

（股份代號：00336） 內幕消息 華寶香精股份有限公司截至 2024 年 9 月 30 日止九個月之 主要會計數據和財務指標 本公告乃由華寶國際控股有限公司（「本公司」）根據香港聯合交易所有限公司證券上市規 則第13.09條刊發及香港法例第571章證券及期貨條例第XIVA部內幕消息條文而作出。 華寶香精股份有限公司（「華寶股份」）為本公司之附屬公司及其股份於深圳證券交易所創 業板上市（代碼：300741）。按深圳證券交易所之相關規定，華寶股份在2024年10月29日已將 其截至2024年9月30日止九個月的第三季度報告刊載於深圳證券交易所創業板信息披露網站 巨潮資訊網（http://www.cninfo.com.cn）。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整 性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而 引致的任何損失承擔任何責任。 HUABAO INTERNATIONAL HOLDINGS LIMITED 華 寶 國 際 控 股 有 限 公 司 * （於百慕達註冊成立之有限公司） 本公司之董事會謹請本公司股東及 ...

Financial Performance - Revenue for the six months ended June 30, 2024, was RMB 1,582,285,000, representing a 3.0% increase from RMB 1,535,704,000 in 2023[9] - Gross profit for the same period was RMB 709,254,000, with a gross profit margin of 44.8%, down from 46.0% in 2023[9] - EBITDA decreased by 40.2% to RMB 262,021,000, resulting in an EBITDA margin of 16.6%, down from 28.5%[9] - Operating profit fell by 64.6% to RMB 100,287,000, with an EBIT margin of 6.3%, down from 18.4%[9] - Profit for the period attributable to equity holders was RMB 29,662,000, a decrease of 80.7% compared to RMB 153,970,000 in 2023[9] - Net cash generated from operating activities was RMB 113,507,000, down 67.7% from RMB 351,235,000[9] - Basic earnings per share decreased by 80.7% to approximately RMB0.92 cents, compared to approximately RMB4.77 cents in 1H 2023[23] - The decline in operating profit was primarily due to a share-based compensation expense of approximately RMB42.184 million recognized for the share incentive scheme[24] - An impairment of goodwill of approximately RMB29.309 million and an impairment of assets of approximately RMB20.189 million were recognized during the Reporting Period[24] - Profit before income tax for the six months ended June 30, 2024, was RMB 78,999,000, down 72.4% from RMB 286,738,000 in the previous year, mainly due to various impairment provisions and increased expenses[111] - The Group's profit for the period was RMB 46,286,000, a decrease of 76.9% compared to RMB 200,353,000 for the same period last year, driven by significant impairment charges and increased marketing expenses[116] Market Expansion and Strategy - The management is exploring overseas markets, particularly in Southeast Asia, to expand market reach and promote sales[11] - The Group is focusing on overseas market expansion due to insufficient domestic demand, particularly in Southeast Asia[13] - The Group plans to focus on developing domestic and Southeast Asia markets for flavors and fragrances, aiming to generate more sales through research and analysis[90] - The Group will continue to invest in R&D for emerging tobacco products and expand international markets to promote product sales[90] Production and Efficiency - The company has implemented a "Lean Production" program to improve resource use and production efficiency[11] - The implementation of "lean production" plans in more factories aims to enhance resource utilization and production efficiency[13] - The Group has implemented a "Lean Production" program to optimize production efficiency and reduce costs, aiming to improve profit margins[51] - The implementation of the "Lean Production" program aims to reduce costs and increase efficiency across various product lines[90] Research and Development - The Group invested approximately RMB 121 million in R&D, representing 7.7% of revenue, a slight increase from 7.6% in the previous year[68] - The Group has been granted 7 invention patents and 7 utility model patents related to food flavors and production equipment, enhancing its market capacity[69] - The Group applied for 21 patents in the tobacco raw materials segment, focusing on HNB cigarette products and production methods[70] - New product categories, such as soup base products, have been developed, with three invention patents applied for enhancing flavor and aroma[75] - The Group applied for three invention patents related to soup base products to enhance technical capabilities in this new product category[76] Financial Position and Cash Flow - As of June 30, 2024, the Group's net current assets were RMB 7,100,491,000, an increase from RMB 6,975,409,000 as of December 31, 2023, indicating a stable financial position[117] - Cash and bank balances, including fixed deposits, amounted to RMB 2,183,601,000 as of June 30, 2024, down from RMB 2,539,493,000 at the end of 2023, with over 60.0% held in RMB[119] - The fair value of outstanding bank wealth management products held by the Group as of June 30, 2024, was RMB 3,798,085,000, slightly down from RMB 3,847,748,000 as of December 31, 2023[119] - The Group's debt ratio was 1.8% as of June 30, 2024, down from 3.6% as of December 31, 2023, representing a decrease of 1.8 percentage points[124] - For the six months ended June 30, 2024, net cash generated from investing activities was RMB 39,886,000, a significant recovery from net cash used of RMB 1,261,019,000 in the same period last year[122] Shareholder and Corporate Governance - The shareholders approved the adoption of the 2024 Share Award Scheme and the 2024 Share Option Scheme on May 14, 2024, while terminating the 2022 Share Award Scheme and the 2016 Share Option Scheme[159] - As of June 30, 2024, Director CHU Lam Yiu holds 2,293,408,900 shares, representing 71.00% of the issued share capital[155] - The 2024 Share Award Scheme aims to recognize contributions, attract high-caliber participants, and align their interests with shareholders[188] - The 2024 Share Award Scheme aims to incentivize participants for their contributions to the group's growth and development, aligning their interests with those of shareholders[189] Operational Challenges - The Group's operating profit decreased by 64.6% to RMB 100,287,000, primarily due to goodwill impairment and increased share-based compensation expenses[107] - The Group's cautious approach led to a downward adjustment of future profit forecasts for Yancheng Chunzhus, confirming goodwill impairment of approximately RMB 29.309 million[59] - The financial performance highlights a decrease in both adjusted EBITDA and operating profit compared to the previous year, indicating potential challenges in core operations[150]

Financial Performance - Revenue for the six months ended June 30, 2024, was RMB 1,582,285 thousand, representing a 3.0% increase from RMB 1,535,704 thousand in the same period of 2023[2] - Gross profit for the same period was RMB 709,254 thousand, slightly up by 0.4% from RMB 706,732 thousand[2] - EBITDA decreased by 40.2% to RMB 262,021 thousand, with an EBITDA margin of 16.6%, down from 28.5% in the previous year[2] - Operating profit fell by 64.6% to RMB 100,287 thousand, resulting in an operating margin of 6.3%, compared to 18.4% in the prior year[2] - Net profit for the period was RMB 46,286 thousand, a significant decline of 76.9% from RMB 200,353 thousand in the same period last year[2] - Earnings attributable to equity holders of the company were RMB 29,662 thousand, down 80.7% from RMB 153,970 thousand[2] - Basic and diluted earnings per share decreased to RMB 0.92 from RMB 4.77, reflecting an 80.7% drop[2] - Adjusted EBITDA was RMB 356,172 thousand, down 21.7% from RMB 455,077 thousand, with an adjusted EBITDA margin of 22.5%[2] Assets and Liabilities - Total assets as of June 30, 2024, were RMB 15,438,254 thousand, a decrease from RMB 16,002,111 thousand as of December 31, 2023[6] - Cash and bank deposits amounted to RMB 2,183,601 thousand, down from RMB 2,539,493 thousand at the end of 2023[6] - As of June 30, 2024, total equity amounted to RMB 14,170,258 thousand, a decrease from RMB 14,271,137 thousand as of December 31, 2023, representing a decline of approximately 0.8%[7] - The total liabilities decreased to RMB 1,267,996 thousand from RMB 1,730,974 thousand, indicating a reduction of about 26.7%[7] Segment Performance - The segment performance for the flavor and food ingredients business showed a profit of RMB 137,858 thousand, while the tobacco raw materials segment reported a loss of RMB 3,417 thousand[13] - The group's sales revenue for the flavor and food ingredients business was approximately RMB 652 million, a decrease of 4.3% year-on-year, accounting for about 41.2% of total revenue[45] - The operating profit for the flavor and food ingredients segment was approximately RMB 138 million, down 42.1% year-on-year, with an operating profit margin of 21.1%, a decrease of 13.8 percentage points[45] - The sales revenue for the tobacco raw materials business was approximately RMB 164 million, a decrease of 12.5% year-on-year, accounting for about 10.4% of total revenue[50] Research and Development - Research and development expenses increased to RMB 121,362,000 for the six months ended June 30, 2024, compared to RMB 116,321,000 in 2023, representing a growth of 4.4%[19] - Research and development expenses amounted to approximately RMB 121 million, representing 7.7% of sales revenue, an increase of 0.1 percentage points year-on-year[58] Cash Flow and Financing - The net cash generated from investment activities for the six months ended June 30, 2024, was RMB 39,886,000, compared to a net cash outflow of RMB 1,261,019,000 for the same period in 2023[74] - The net cash used in financing activities for the six months ended June 30, 2024, was RMB 444,621,000, which included repayment of bank loans of RMB 374,250,000[75] - Total loans as of June 30, 2024, were RMB 219,000,000, significantly reduced from RMB 455,250,000 as of December 31, 2023, marking a decrease of about 52.1%[31] Expenses - Total government grants received decreased to RMB 68,021,000 in 2024 from RMB 91,953,000 in 2023, indicating a reduction of 26%[17] - Total expenses for employee benefits increased to RMB 370,992,000 in 2024 from RMB 309,362,000 in 2023, reflecting a rise of 19.9%[19] - Selling and marketing expenses increased by 16.5% to RMB 165,416,000, representing about 10.5% of total revenue, up from 9.2% in the previous year[66] - Administrative expenses rose by 17.7% to RMB 458,285,000, accounting for approximately 29.0% of total revenue, an increase of 3.6 percentage points from the previous year[67] Dividends and Shareholder Returns - The company plans to declare an interim dividend of RMB 0.3 per share for the six months ended June 30, 2024, compared to RMB 1.6 cents per share in 2023[27] - The company declared an interim cash dividend of HKD 0.3 per share and a special dividend of HKD 3.2 per share for the six months ending June 30, 2024, compared to HKD 1.6 and HKD 1.9 per share in 2023 respectively[86] Operational Strategies - The company plans to continue expanding its product lines in the flavor and food ingredients sector, focusing on R&D and innovation[12] - The group is focusing on expanding overseas markets and implementing lean production strategies to enhance efficiency and reduce costs[39] - The company is focusing on digital transformation with four operational platforms, improving operational efficiency and data management capabilities[60] Impairments and Losses - The decline in operating profit was primarily due to a share-based compensation expense of approximately RMB 42.18 million related to a stock incentive plan approved on January 5, 2024[43] - The group recognized goodwill impairment of approximately RMB 29.31 million and asset impairment of approximately RMB 20.19 million during the reporting period[43] - The company has adjusted the future profit forecast for Yancheng Chunzhu due to external economic challenges, confirming a goodwill impairment of approximately RMB 29.31 million[55] Market Conditions and Future Outlook - The company is evaluating the impact of new accounting standards on its financial statements, which may affect future reporting[11] - The group plans to focus on domestic and Southeast Asian market expansion, new product development, and cost reduction strategies to enhance operational efficiency[61]